Indian Journal of Research in Homoeopathy
Not a member yet
697 research outputs found
Sort by
Obstinate chronic venous ulcer treated with the homoeopathic medicine Silicea: A case report
Get PDFIntroduction: Vascular leg ulcers are highly prevalent conditions that have difficult management, a high sanitary cost and an impact on the patient’s quality of life. Individualised homoeopathic treatment could be a safe and affordable therapeutic option for venous ulcers. Case Summary: A 35-year-old male was treated with homoeopathic medication for an intractable case of chronic venous ulcer. Individualised homoeopathic medicine, Silicea, was prescribed after thorough case-taking, which led to improvement in subjective and objective symptoms. The Modified Naranjo Criteria score was 8 following the homoeopathic treatment, which shows positive causal attribution of the individualised homoeopathic medicine Silicea in this case. To draw more firm conclusion about the role of classical Homoeopathy in the management of peripheral vascular diseases, more in-depth research is necessary
Laryngopharyngeal reflux disease with vocal cord oedema treated with individualised homoeopathic medicine: A case report
No full textIntroduction: The diagnosis of laryngopharyngeal reflux disease (LPRD) is still ambiguous due to limited and cumbersome diagnostic standards. To achieve regression of both symptoms and laryngeal findings due to LPRD, it typically requires more vigorous and sustained treatment. In certain patients with chronic acid or non-acid reflux, surgery may be helpful. Case Summary: This is the case of a 68-year-old man who was diagnosed with LPRD and had vocal cord oedema. Individualised homoeopathic medicine, Natrum sulphuricum, was prescribed, and the patient improved steadily in terms of signs and symptoms and had no further complaints at the end of 16 months. The patient’s improvement was assessed using the outcome related to the impact on daily living scale (ORIDL). Clinical improvement was correlated with objective evidence from the laryngoscopy report. The Modified Naranjo Criteria for Homoeopathy score (+8 on the ‘−6 to +13’ scale) determines if the patient’s progress can be attributed to the homoeopathic treatment. This case report implies that homoeopathy may be an appropriate choice for treating LPRD with vocal cord oedema cases. This is the rare instance of a documented LPRD case report associated with vocal cord oedema followed by a successful therapeutic homoeopathic treatment. For further conclusion regarding the disease, more studies are warranted
Cutaneous warts treated with a single dose of the homoeopathic medicine Carcinosin 200C: An evidence-based case report
No full textIntroduction: Cutaneous warts are hyperkeratotic protrusions over the skin caused by human papilloma virus (HPV). These are common throughout the world. Cutaneous warts can occur at any age but are unusual in early childhood and infancy. Warts are often diagnosed clinically on physical examination, but some dysplastic lesions may require laboratory confirmation of HPV. Spontaneous clearance is not always possible, and offering a reliable prognosis to the individual case is impossible. Even though warts are frequently encountered in the day-to-day practice of homoeopathy, and the results are promising, there are limited research studies available in the online database. Case Summary: A 5-year-old female child was brought to OPD of National Homoeopathy Research Institute in Mental Health, Kottayam for the treatment of warts on different parts of body. After careful case-taking and construction of the totality of symptoms, Carcinosin 200C was prescribed in a single dose. In response to the medicine, warts began to reduce in size and eventually fell off in two months. The causal attribution for the outcome was assessed using MONARCH inventory for homoeopathy, which scored +9, showing the positive relationship between the intervention and the outcome. Therefore, this case demonstrates the positive role of individualised Homoeopathy in treating cutaneous warts
Ichthyosis vulgaris successfully treated with individualised homoeopathic medicine Dulcamara 200C – An evidence-based case report
No full textIntroduction: Ichthyosis vulgaris (IV) is a hereditary condition that often manifests in infancy but can also exist from birth. It is a recalcitrant disorder relapses often and even shows the least response to various therapeutic options. Extensive literature review have revealed a dearth of appropriate evidence-based documentation on treatment of ichthyosis in Homoeopathy. Case Summary: This is a case of IV in a 20-year-old male, manifested as widespread scaling and itching since childhood. Following homoeopathic principles, Dulcamara 200C was prescribed. Outcome related to impact on daily living (ORIDL) scale was used to evaluate the patient-reported outcome measure subjectively, and the improvement was assessed on the ORIDL scale (score +3). The improvement in quality of life (QoL) was evaluated using the dermatology life quality index questionnaire, and the QoL improved with a score reduced from ‘20’ to ‘0’. Photographs are presented as objective evidence. The Modified Naranjo Criteria for Homeopathy (MONARCH) was used to assess potential causal attribution. The overall score (+8) of MONARCH substantiated the possible causal attribution to homoeopathic treatment. In this instance, the case was successfully resolved with Dulcamara 200C in just 3 months, with no further recurrence. Conclusion: More research with controlled trials is warranted in the future to validate the role of Homoeopathy
Safety of potentised dilutions of Rhus toxicodendron in Wistar albino rats
Get PDFBackground: Rhus toxicodendron (Rhus tox.) is a well-known homoeopathic medicine used to treat inflammatory disorders supported by historical and modern scientific evidence. Objective: The safety testing of 6C, 30C and 200C potencies of Rhus tox. through acute and sub-acute oral toxicity tests as per the Organisation for Economic Cooperation and Development test guidelines. Methods: For the acute oral toxicity study, Rhus tox. (2000 μL/kg) was administered to rats and observed for 14 days. For the subacute oral toxicity study, Rhus tox. (200 μL/kg) was administered for 28 days and additional recovery groups were included to monitor reversibility, persistence, or delayed occurrence of toxic effects for 14 days post-treatment. Histopathological assessments of vital organs were done to detect any signs of toxicity. Results: No mortality occurred during the acute toxicity study at a dose of 2000 μL/kg, indicating an oral LD50 of Rhus tox. \u3e2000 μL/kg. In the sub-acute toxicity study, Rhus tox. administration for 28 days showed no adverse clinical signs, with normal weight gain and feed intake in treated animals. No adverse changes were noticed in the biochemical and haematological parameters of Rhus tox. treated rats. Furthermore, no abnormalities were observed in gross and histopathological examinations of vital organs. Conclusion: The study found that Rhus tox. in 6C, 30C and 200C potencies exhibited a safe toxicological profile, supporting its beneficial pharmacological effects
Management of post-operative breast nodules with Homoeopathy: A case report
No full textIntroduction: Palpable masses after mastectomy are commonly detected by patients or their physicians. Imaging of palpable masses is advised following a complete history and physical examination. This is a case of breast nodules occurring after the removal of cancerous tissue in the breast. Homoeopathy, with its holistic approach, can treat the disease by addressing its multifactorial origin.
Case summary: A 71-year-old female, diagnosed with post-operative breast nodules after surgical excision of mucinous carcinoma portion of the left breast, was treated with individualised homoeopathic treatment for six months with subsequent improvement. This case provides preliminary evidence for the potential usefulness of homoeopathy as an alternative therapy for the treatment of breast nodules
A scientific convention on World Homoeopathy Day: ‘Homoeoparivar – Sarvajan Swasthya, One Health One Family’ – A conference report
Get PDFThe Central Council for Research in Homoeopathy organised a scientific convention on World Homoeopathy Day on April 10th, 2023, at Vigyan Bhavan, New Delhi, to commemorate the 268th birth anniversary of Dr. Christian Friedrich Samuel Hahnemann. The conference’s theme was ‘Sarvajan Swasthya Homoeoparivar – One Health, One Family’. The convention’s aim was to come together in this profession as a Family/Parivar to collate the experiences of policymakers, researchers and practitioners to create a harmonious growth of Homoeopathy and to achieve the potential that Homoeopathy reaches each household of the country as the first line of treatment
A randomised, double-blind, placebo-controlled and parallel-arm trial to assess the effect of homoeopathic medicines on chronic rhinosinusitis
Get PDFBackground: Chronic rhinosinusitis (CRS) is a significant health problem impacting health related quality of life.
Objectives: This study assesses the efficacy of individualised homoeopathy (IH) in LM potency in CRS.
Methods: A randomised, double-blind and placebo-controlled trial on patients with CRS was undertaken at four institutes, from July 2012 to December 2013. Eligible participants were randomised to IH in LM-potencies (n = 60) or a similar placebo (n = 60). Primary outcome was change in the total symptoms score (TSS) (area under the curve [AUC]) and in sinus nasal outcome test 22 over 3 months. Intention-to-treat approach was used for analyses.
Results: TSS AUC over 3 months was less in the homoeopathy group compared to the placebo group but was statistically insignificant (IH: 1303.1 ± 612.2; P = 1380.1 ± 811.8; 95% CI: −336.9, 182.9; P = 0.56). The absolute difference in TSS from baseline had a statistically significant difference at day 60 (mean difference = 4; 95% CI: 0.3–7.7, P = 0.03) and day 75 (mean difference =3.8; 95%: 0.1–7.5, P = 0.04) favouring homoeopathy. The global assessment by the investigator and patient showed satisfactory improvement at day 60 mean difference = 0.6, 95% CI: 0.27–0.86, P = 0.0001 and day 75 mean difference = 0.5, 95% CI: 0.27–0.84, P = 0.0001, respectively. A positive trend was observed in rhinoscopy score in homoeopathy group (mean difference: 0.9, 95% CI: −0.00–1.8, p=0.05). There was no difference in computed tomography scan scores of paranasal sinuses between the groups.
Conclusion: This study provides a positive trend to support the effect of individually selected homoeopathic remedies in patients with CRS and warrants further evaluation